SKILLMAN, N.J. — Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share. The revised offer represents a premium of ...

ProPhase Labs, Inc. PRPH shares rallied 9.1% in the last trading session to close at $14.15. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

ProPhase Labs (PRPH) announced the closing of a private placement financing with two investors for $3 million in senior secured convertible notes ...

Company to hold a conference call Thursday, May 11, 2023, at 11:00 AM ET. Garden City, NY, May 11, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics ...

ProPhase Labs press release (NASDAQ:PRPH): FY GAAP EPS of $1.02 misses by $0.10. Revenue of $122.65M (+55.2% Y/Y) beats by $1.31M. cash and cash equivalents and restricted cash as of December 31 ...

ProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers ...

ProPhase Labs earnings missed by $1.62, revenue topped estimates. Open in App ...

--ProPhase Labs, Inc., a next-generation biotech, genomics and diagnostics company, is pleased to announce that Ted Karkus, CEO, has been named one of Inc Magazine’ s 10 Most Innovative ...

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its ...